We are sad to report the death of our Serzone
client, Cassie Jo Geisenhof, 19, who died April 12, 2004 after
long-term complications resulting from her liver transplant four
years earlier. Cassie, at age 15, suffered liver failure and
underwent a liver transplant three months after being prescribed
Serzone for treatment of depression.
Cassie's story, which has received
national media attention, is only one tragic example of the deadly
affects of dangerous prescription medication and further supports
recent efforts to ban Serzone in the United States. Serzone has
already been banned or removed from the market in Canada, Europe,
and Australia as a result of numerous reports of liver failure
associated with its use.